Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP

Cytokine

Volumn 40, Issue 2, 2007, Pages 89-97

  Birner, Christoph M ^a   Ulucan, Coskun ^a   Fredersdorf, Sabine ^a   Rihm, Munhie ^a   Löwel, Hannelore ^b   Stritzke, Jan ^c   Schunkert, Heribert ^c   Hengstenberg, Christian ^a   Holmer, Stephan ^a   Riegger, Günter ^a   Luchner, Andreas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cytokines; Experimental heart failure; Interleukin 6; Natriuretic peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 6;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PROTEIN PRECURSORS; RABBITS; RNA, MESSENGER; SPECIES SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

ANIMALIA;

EID: 36549032198     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.08.009     Document Type: Article

References (35)

1. Abdallah A.N., Billes M.A., Attia Y., Doutremepuich C., Cassaigne A., and Iron A. Evaluation of plasma levels of tumor necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy. Eur Heart J 18 6 (1997) 1024-1029
2. Ancey C., Menet E., Corbi P., Fredj S., Garcia M., Rucker-Martin C., et al. Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation. Cardiovasc Res 59 1 (2003) 78-85
3. Birks E.J., Latif N., Owen V., Bowles C., Felkin L.E., Mullen A.J., et al. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation 104 12 Suppl. 1 (2001) I233-I240
4. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 19 (2003) 2317-2322
5. Cockroft D., and Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
6. Deliargyris E.N., Raymond R.J., Theoharides T.C., Boucher W.S., Tate D.A., and Dehmer G.J. Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 86 9 (2000) 913-918
7. Deten A., Volz H.C., Briest W., and Zimmer H.G. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55 2 (2002) 329-340
8. Deten A., Volz H.C., Briest W., and Zimmer H.G. Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats. Mol Cell Biochem 242 1-2 (2003) 47-55
9. Devereux R., Koren M., de Simone P., Okin P.M., and Kligfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 14 (1993) 8-15
10. Elsner D., and Riegger G.A. Experimental heart failure produced by rapid ventricular pacing in the dog. J Card Fail 1 3 (1995) 229-247
11. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 19 (2003) 1735-1743
12. Gwechenberger M., Hulsmann M., Berger R., Graf S., Springer C., Stanek B., et al. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure. J Heart Lung Transplant 23 7 (2004) 839-844
13. Hirota H., Izumi M., Hamaguchi T., Sugiyama S., Murakami E., Kunisada K., et al. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels 19 5 (2004) 237-241
14. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 8 (2005) 948-954
15. Jeron A., Kaiser T., Straub R.H., Weil J., Riegger G.A., and Muders F. Myocardial IL-6 regulation by neurohormones-an in vitro superfusion study. Brain Behav Immun 17 4 (2003) 245-250
16. Koglin J., Pehlivanli S., Schwaiblmair M., Vogeser M., Cremer P., and vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38 7 (2001) 1934-1941
17. Luchner A., Bröckel U., Muscholl M., Hense H.W., Döring A., Riegger G.A.J., et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res 53 (2002) 720-727
18. Luchner A., Burnett Jr. J.C., Jougasaki M., Hense H.W., Heid I.M., Muders F., et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 18 8 (2000) 1121-1128
19. Luchner A., Hengstenberg C., Lowel H., Buchner S., Schunkert H., Riegger G.A., et al. NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points. J Card Fail 11 5 Suppl (2005) S21-S27
20. Luchner A., Muders F., Dietl O., Friedrich E., Blumberg F., Protter A.A., et al. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res 51 3 (2001) 601-607
21. McDonagh T.A., Holmer S., Raymond I., Luchner A., Hildebrant P., and Dargie H.J. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6 3 (2004) 269-273
22. Maisel A.S., Clopton P., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., et al. BNP multinational study investigators impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147 6 (2004) 1078-1084
23. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Breathing not properly multinational study investigators rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
24. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 7 (2004) 647-654
25. Orus J., Roig E., Perez-Villa F., Pare C., Azqueta M., Filella X., et al. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 19 5 (2000) 419-425
26. Pan J.P., Liu T.Y., Chiang S.C., Lin Y.K., Chou C.Y., Chan W.L., et al. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure. J Chin Med Assoc 67 5 (2004) 222-228
27. Plenz G., Song Z.F., Reichenberg S., Tjan T.D., Robenek H., and Deng M.C. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy. Thorac Cardiovasc Surg 46 4 (1998) 213-216
28. Raymond R.J., Dehmer G.J., Theoharides T.C., and Deliargyris E.N. Elevated interleukin-6 levels in patients with symptomatic left ventricular systolic dysfunction. Am Heart J 141 3 (2001) 435-438
29. Richards M., and Troughton R.W. NT-proBNP in heart failure: therapy decisions and monitoring. Eur J Heart Fail 6 3 (2004) 351-354
30. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantification of the left venticle by two-dimensional echocardiography. J Am Soc Echocardiog 2 5 (1989) 358-367
31. Stevens TL, Borgeson DD, Luchner A, Wennberg PW, Redfield MM, Burnett Jr JC. A modified model of tachycardia-induced cardiomyopathy: insights into humoral and renal adaptations. In: Spinale F, editor. Tachycardia-induced cardiomyopathy, Futura Press, 1996.
32. Suzuki H., Sato R., Sato T., Shoji M., Iso Y., Kondo T., et al. Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 100 3 (2005) 415-420
33. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 5 (1996) 1201-1206
34. Wei T., Zeng C., Chen Q., Chen L., Zhao R., Lu G., et al. Plasma BNP levels are determined by the severity of left ventricular systolic dysfunction but not the types of underlying heart disease. Acta Cardiol 60 3 (2005) 303-306
35. Wilson J.R., Douglas P., Hickey W.F., et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 75 (1987) 857-867